In Reply to the Letter to the Editor Regarding "Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme"
World Neurosurg
.
2019 Aug;128:617.
doi: 10.1016/j.wneu.2019.05.078.
Authors
Julius Höhne
1
,
Karl-Michael Schebesch
2
,
Camilla de Laurentis
3
,
Mehmet Osman Akçakaya
4
,
Christian Bonde Pedersen
5
,
Alexander Brawanski
2
,
Frantz Rom Poulsen
5
,
Talat Kiris
4
,
Claudio Cavallo
3
,
Morgan Broggi
3
,
Paolo Ferroli
3
,
Francesco Acerbi
3
Affiliations
1
Department of Neurosurgery, University Medical Center Regensburg, Regensburg, Germany. Electronic address: julius.hoehne@ukr.de.
2
Department of Neurosurgery, University Medical Center Regensburg, Regensburg, Germany.
3
Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
4
Department of Neurosurgery, Liv Hospital, Istanbul, Turkey.
5
Department of Neurosurgery, Odense University Hospital, Odense, Denmark.
PMID:
31675765
DOI:
10.1016/j.wneu.2019.05.078
No abstract available
Publication types
Letter
Comment
MeSH terms
Brain Neoplasms / surgery*
Fluorescein
Glioblastoma / surgery*
Humans
Neoplasm Recurrence, Local / surgery
Neurosurgical Procedures
Substances
Fluorescein